APA

Colly L. P., Willemze R., Honders W., vd Hoorn F. & Edelbroek P. M. (19850807). In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML). : Seminars in oncology.

Chicago

Colly L P, Willemze R, Honders W, vd Hoorn F and Edelbroek P M. 19850807. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML). : Seminars in oncology.

Harvard

Colly L. P., Willemze R., Honders W., vd Hoorn F. and Edelbroek P. M. (19850807). In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML). : Seminars in oncology.

MLA

Colly L P, Willemze R, Honders W, vd Hoorn F and Edelbroek P M. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML). : Seminars in oncology. 19850807.